bimekizumab
ucb pharmaceuticals
['be mobile', 'bimekizumab', 'ease,(-please),(-disease),(-incrrease),(-decrease)', 'axspa']
ab409 #acr22 bimekizumab (il17a, il17f) &amp; pros
p mease on be mobile 1 &amp; 2
bkz 160 mg q4w vs pbo
254 pts w nr-axspa, 332 w as
improvement in spinal pain, nocturnal pain, morning stiffness, facit-fatigue for pts with as and nr-axspa, statistically signif diff at wk 16 
Rheumatologist at Institute for Rheumatic and Autoimmune Disease at Overlook Hospital, proud Hopkins alum, health care advocate, Eagles fan entering Giants land